These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12659677)

  • 1. Effect of adeno-associated virus-specific immunoglobulin G in human amniotic fluid on gene transfer.
    Boyle MP; Enke RA; Mogayzel PJ; Guggino WB; Martin DB; Agarwal S; Zeitlin PL
    Hum Gene Ther; 2003 Mar; 14(4):365-73. PubMed ID: 12659677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium.
    Boyle MP; Enke RA; Adams RJ; Guggino WB; Zeitlin PL
    Mol Ther; 2001 Aug; 4(2):115-21. PubMed ID: 11482982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes.
    Cottard V; Valvason C; Falgarone G; Lutomski D; Boissier MC; Bessis N
    J Clin Immunol; 2004 Mar; 24(2):162-9. PubMed ID: 15024183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype.
    Boissier MC; Lemeiter D; Clavel C; Valvason C; Laroche L; Begue T; Bessis N
    Hum Gene Ther; 2007 Jun; 18(6):525-35. PubMed ID: 17532727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
    Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
    J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
    J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient enzyme-linked immunosorbent assay for rapid screening of anti-adeno-associated virus neutralizing antibodies.
    Ito T; Yamamoto S; Hayashi T; Kodera M; Mizukami H; Ozawa K; Muramatsu S
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):508-10. PubMed ID: 19729501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.
    Lipshutz GS; Gruber CA; Cao Y ; Hardy J; Contag CH; Gaensler KM
    Mol Ther; 2001 Mar; 3(3):284-92. PubMed ID: 11273769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
    Le HT; Yu QC; Wilson JM; Croyle MA
    J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In utero recombinant adeno-associated virus gene transfer in mice, rats, and primates.
    Garrett DJ; Larson JE; Dunn D; Marrero L; Cohen JC
    BMC Biotechnol; 2003 Sep; 3():16. PubMed ID: 14519209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
    Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.